A wide-ranging conversation on the Hims House podcast looks at where peptides stand today, including the rumors, the regulatory uncertainty, the real concerns, and the road ahead.
APC CEO Scott Brunner, CAE, discussed the guardrails that APC has proposed to FDA and the two meetings APC held with the agency in a good conversation about a complicated moment for pharmacy compounding.
Watch the full episode on YouTube.